Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

NCT02001168 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

392

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Docetaxel
DRUG: rh-Endostatin
DRUG: Cis-platinum

Sponsor

Xinjiang Medical University